ClearPoint Neuro (CLPT) Net Cash Flow Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) Net Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 76.43% |
| 10 | ClearPoint Neuro | 430.50 Mn | 394.91 Mn | 7.76 Mn | -35.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.51% |
| Dec 31, 2025 | 682.16% |
| Sep 30, 2025 | 70.73% |
| Jun 30, 2025 | 1,270.57% |
| Mar 31, 2025 | -163.19% |
| Dec 31, 2024 | -22.21% |
| Sep 30, 2024 | -431.20% |
| Jun 30, 2024 | -153.68% |
| Mar 31, 2024 | 309.74% |
| Dec 31, 2023 | -113.50% |
| Sep 30, 2023 | 55.90% |
| Jun 30, 2023 | 117.88% |
| Mar 31, 2023 | -30.82% |
| Dec 31, 2022 | 351.36% |
| Sep 30, 2022 | -24.24% |
| Jun 30, 2022 | -683.86% |
| Mar 31, 2022 | -109.94% |
| Dec 31, 2021 | -165.18% |
| Sep 30, 2021 | -183.32% |
| Jun 30, 2021 | -253.18% |